Denis Drygin - 04 Feb 2022 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Signature
Christopher Aker, Attorney in Fact
Issuer symbol
RGLS
Transactions as of
04 Feb 2022
Net transactions value
+$5,362
Form type
4
Filing time
07 Feb 2022, 16:09:32 UTC
Previous filing
26 Jan 2022
Next filing
01 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Purchase $5,362 +23,314 $0.2300 23,314 04 Feb 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.